Bio-Pharmaceuticals Market in India 2017

Array
(
    [id] => 1654533
    [discount] => ENTERPRISE WIDE LICENCE-30--------
    [isbn] => 
    [title] => Bio-Pharmaceuticals Market in India 2017
    [upcommingtext] => 
    [seo_url] => bio-pharmaceuticals-market-in-india
    [shortdesc] => 
    [meta_title] => Bio-Pharmaceuticals Market in India 2018-2023
    [keyword] => Bio Pharma Market in India, Biopharma industry in India, Generic medicine market in India,   Biopharmaceutical market 2023, Biopharmaceuticals Market Size, Growth in biotechnology, Growth and future of biopharmaceuticals
    [description] => The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023
    [curr] => USD
    [category] => 1200
    [publisher] => 48
    [published_date] => 2018-12-28
    [country] => 241
    [author_name] => 
    [page_num] => 65
    [abstract] => 

Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.

Bio-pharmaceuticals Industry in India (2018-2023)

Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.

Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. ‘Pharma Vision 2020’ has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.

Key growth drivers of the market:

India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.
Key deterrents to the growth of the market:
It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
 

Companies covered:
Biocon Ltd.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Wockhardt Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.
 

[table_of_contents] =>

Chapter 1: Executive summary
 
 Chapter 2: Socio-economic indicators
 
 Chapter 3: Introduction

 
 1.1. Bio-pharmaceuticals market definition and structure
 1.2. Bio-pharmaceuticals value chain
 
 Chapter 4: Global pharmaceuticals market
 
 4.1. Market overview
 4.2. Market segmentation
 4.2.1. Pharmaceuticals market value - country-wise split (2017)
 
 USA
 Japan
 China
 Germany
 France
 Others
 4.2.2. Pharmaceutical spending - region-wise split (2020e)
 
 USA
 EU-5
 Others
 4.2.3. Pharmaceuticals market players - ranking (2017)
 4.3. Bio-pharmaceuticals sales growth (2007-2017)
 
 Chapter 5: India bio-pharmaceuticals market
 
 5.1. Market overview
 5.2. Market size and growth forecast - value-wise (FY 2016-FY 2023e)
 5.3. Market segmentation
 5.3.1. Revenue-wise market breakup (FY 2016)
 5.3.2. Top five pharmaceutical company market share (2018)
 
 Cipla
 Aurobindo Pharma
 Lupin
 Others
 5.4. Recent investments in the market
 5.5. Government initiatives
 5.6. Biotechnology and pharmaceutical research and development (R&D) hubs in India - overview
 5.7. Porter’s five forces analysis
 
 Chapter 6: Trade analysis
 
 6.1. Export of bio-pharmaceuticals
 
 Value-wise
 Volume-wise
 Country-wise
 6.2. Import of bio-pharmaceuticals
 
 Value-wise
 Volume-wise
 Country-wise
 
 Chapter 7: Key growth drivers of the market
 
 Chapter 8: Key deterrents to the growth of the market
 
 Chapter 9: Competitive landscape

 9.1. Biocon Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 o Production capacities
 9.2. Cadila Healthcare Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 o Production capacities
 9.3. Dr Reddy’s Laboratories Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.4. Panacea Biotec Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Therapy-wise market share
 o Therapy-wise sales
 o Annual research & development spends
 o Business segments, geographic segments
 9.5. Wockhardt Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Projects overview
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.6. GSK Pharmaceuticals Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.7. Bharat Biotech International Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 9.8. Bharat Serums and Vaccines Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Key financial indicators
 9.9. Indian Immunologicals Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Key financial indicators
 9.10. Serum Institute of India Pvt. Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 
 Chapter 10: Recent developments
 
 Chapter 11: Appendix

 11.1. Research methodology
 
 Companies Profiled
 
 Biocon Ltd.
 Cadila Healthcare Ltd.
 Dr Reddy’s Laboratories Ltd.
 Panacea Biotec Ltd.
 Wockhardt Ltd.
 GSK Pharmaceuticals Ltd.
 Bharat Biotech International Ltd.
 Bharat Serums and Vaccines Ltd.
 Indian Immunologicals Ltd.
 Serum Institute of India Pvt. Ltd.

[list_of_tables] => [list_of_figures] => [sample_page] => [brochure] => [new_price] => ENTERPRISE WIDE LICENCE-950 )
discount aarkstore

Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.

Bio-pharmaceuticals Industry in India (2018-2023)

Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.

Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. ‘Pharma Vision 2020’ has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.

Key growth drivers of the market:

India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.
Key deterrents to the growth of the market:
It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.
 

Companies covered:
Biocon Ltd.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Wockhardt Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.
 

Chapter 1: Executive summary
 
 Chapter 2: Socio-economic indicators
 
 Chapter 3: Introduction

 
 1.1. Bio-pharmaceuticals market definition and structure
 1.2. Bio-pharmaceuticals value chain
 
 Chapter 4: Global pharmaceuticals market
 
 4.1. Market overview
 4.2. Market segmentation
 4.2.1. Pharmaceuticals market value - country-wise split (2017)
 
 USA
 Japan
 China
 Germany
 France
 Others
 4.2.2. Pharmaceutical spending - region-wise split (2020e)
 
 USA
 EU-5
 Others
 4.2.3. Pharmaceuticals market players - ranking (2017)
 4.3. Bio-pharmaceuticals sales growth (2007-2017)
 
 Chapter 5: India bio-pharmaceuticals market
 
 5.1. Market overview
 5.2. Market size and growth forecast - value-wise (FY 2016-FY 2023e)
 5.3. Market segmentation
 5.3.1. Revenue-wise market breakup (FY 2016)
 5.3.2. Top five pharmaceutical company market share (2018)
 
 Cipla
 Aurobindo Pharma
 Lupin
 Others
 5.4. Recent investments in the market
 5.5. Government initiatives
 5.6. Biotechnology and pharmaceutical research and development (R&D) hubs in India - overview
 5.7. Porter’s five forces analysis
 
 Chapter 6: Trade analysis
 
 6.1. Export of bio-pharmaceuticals
 
 Value-wise
 Volume-wise
 Country-wise
 6.2. Import of bio-pharmaceuticals
 
 Value-wise
 Volume-wise
 Country-wise
 
 Chapter 7: Key growth drivers of the market
 
 Chapter 8: Key deterrents to the growth of the market
 
 Chapter 9: Competitive landscape

 9.1. Biocon Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 o Production capacities
 9.2. Cadila Healthcare Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 o Production capacities
 9.3. Dr Reddy’s Laboratories Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.4. Panacea Biotec Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Therapy-wise market share
 o Therapy-wise sales
 o Annual research & development spends
 o Business segments, geographic segments
 9.5. Wockhardt Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Projects overview
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.6. GSK Pharmaceuticals Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Financial snapshot (total income, net profit/loss)
 o Key ratios
 o Annual research & development spends
 o Business segments, geographic segments
 9.7. Bharat Biotech International Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 9.8. Bharat Serums and Vaccines Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Key financial indicators
 9.9. Indian Immunologicals Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 o Key financial indicators
 9.10. Serum Institute of India Pvt. Ltd.
 o Corporate information
 o Business description
 o Products and services
 o Key people
 
 Chapter 10: Recent developments
 
 Chapter 11: Appendix

 11.1. Research methodology
 
 Companies Profiled
 
 Biocon Ltd.
 Cadila Healthcare Ltd.
 Dr Reddy’s Laboratories Ltd.
 Panacea Biotec Ltd.
 Wockhardt Ltd.
 GSK Pharmaceuticals Ltd.
 Bharat Biotech International Ltd.
 Bharat Serums and Vaccines Ltd.
 Indian Immunologicals Ltd.
 Serum Institute of India Pvt. Ltd.


Bio-Pharmaceuticals Market in India 2017

The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023

USD 950 View Report

Global Bio-pharmaceuticals Market Size and Forecast to 2021

Bio-pharmaceuticals Report by Material, Application, and Geography Global Forecast to 2021 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main

USD 1990 View Report

Cystinosis - Market Insights, Epidemiology, and Market Forecast-2028

Cystinosis - Market Insights, Epidemiology, and Market Forecast-2028 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Cystinosis in the

USD 6250 View Report

Cutaneous T- Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2028

Cutaneous T- Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2028 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends

USD 3250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available